SynthesisOrphanet journal of rare diseases2019

Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis.

Min Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.